Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Autism Spectrum Disorder
NCT03033784Phase 2Completed
- Sponsor
- Emory University
- Start
- May 2017
- Primary completion
- Oct 2018
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD), sponsored by Emory University. Started May 2017; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03033784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03033784.